Advertisement
Advertisement
November 10, 2025
Embolization Inc.’s Polymer-Based NED Coil Used in First Procedure
November 10, 2025—Embolization, Inc. announced that its polymer-based coil intended for arterial and venous embolization in peripheral vasculature was used in its first procedure. The company announced FDA 510(k) clearance for its Nitinol Enhanced Device (NED) in June 2025.
According to Embolization, the NED uses the company’s shape-memory biocompatible polymers that are intended to achieve better vascular occlusion while minimizing artifacts in MRI and CT imaging that occur with traditional metal devices. While reducing imaging artifact, the NED is still radiopaque under fluoroscopy even though the CT/MRI imaging artifact is minimal, noted the company in its press release.
Mark J. Garcia, MD, conducted the initial endovascular procedure at EndoVascular Consultants in Wilmington, Delaware. The company explained that he used the embolization coil to treat a female patient’s painful pelvic varices and chronic pelvic pain of venous origin—previously referred to as pelvic congestion syndrome.
“I see big advantages to using an embolic coil that has little or no artifact, as compared to the current coils and plugs,” commented Dr. Garcia in the company’s press release.
Advertisement
Advertisement
